Please login to the form below

Not currently logged in
Email:
Password:

Amgen appoints R Sanders Williams to board of directors

He is president of Gladstone Institutes

R Sanders WilliamsAmgen has appointed R Sanders Williams to its board of directors.

Williams currently serves as the president of Gladstone Institutes, a non-profit biomedical research enterprise, and is also a professor of medicine at the University of California, San Francisco.

Robert Bradway, chairman and CEO of Amgen, said: “We are pleased to welcome Dr Sandy Williams to the Amgen Board. Dr Williams' deep and distinguished experience in academic medicine and his direct experience in our industry will both be of immense value as we extend Amgen's therapeutic and geographic reach to serve more patients.”

Williams will serve on the corporate responsibility and compliance committee and the governance and nominating committee of the board. Following his appointment, the board will comprise of 13 directors, 12 of whom are independent.

He has previous experience as a director at a pharma company, serving on the board of Bristol Myers-Squibb 2006 until 2013. His healthcare career includes spells as chief of cardiology and director of the Ryburn Center for Molecular Cardiology at the University of Texas and as senior vice chancellor of the Duke University School of Medicine.

22nd October 2014

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics